Of the toxicities associated with conventional forms of treatment for head and neck cancers,
probably none has such a consistent legacy as oral mucositis. Despite the fact that mucosal …

Oral mucositis remains one of the most common and troubling side effects of standard
chemoradiation regimens used for the treatment of head and neck cancer. Virtually all …

Oropharyngeal mucositis is a common and treatment-limiting side effect of cancer therapy.
Severe oral mucositis can lead to the need to interrupt or discontinue cancer therapy and …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

Mucosal damage is one of the most common adverse effects of radiotherapy and of cytotoxic
therapy for cancer. With prevalence between 10% and 100%, depending of the cytotoxic …

Oral mucositis is a common complication in cancer patients receiving chemotherapy and/or
radiation therapy. Nearly all patients undergoing myeloablative therapy for stem-cell or bone …

Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …

Oral mucositis is a common toxicity of high-dose chemotherapy and upper mantle head and
neck radiation. Published evidence from the past 14 months provides insight into the …

Chemotherapy‐and radiotherapy‐induced oral mucositis represents a therapeutic challenge
frequently encountered in cancer patients. This side effect causes significant morbidity and …

Oral and pharyngeal mucositis present significant management problems for patients
undergoing radiation for head and neck cancers. The incidence and severity of these …